Scientists hunt for genes behind worst cases of rare eye condition
NCT ID NCT02886611
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is looking at 60 people with a genetic eye surface disease called limbal stem cell deficiency. Researchers want to find out if certain gene changes are linked to more severe disease. They will compare patients' genes with their eye health to look for patterns. This is an observational study, so it does not test any new treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors predict which patients with genetic eye surface disease will have the most severe symptoms, guiding earlier and more personalized care.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly improve any patient's condition, and the genetic links found may not lead to new therapies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIMBAL STEM CELL DEFICIENCY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fondation Ophtalmologique Adolphe de Rothschild
RECRUITINGParis, 75019, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Lab-grown stem cells may restore damaged eye surfaces
- 500-Patient study aims to map rare eye Disease's natural course
- New eye drops aim to repair cornea damage in rare vision disorder
- Oval lenses may finally solve scleral lens discomfort
- Scientists hunt for biomarkers to unlock rare eye disease treatments
- Could Lab-Grown eye cells restore sight? new trial begins